Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: An evidence-based review

Best Practice and Research: Clinical Haematology

Volumn 19, Issue 1, 2006, Pages 113-126

  Ramsey, Glenn ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Blood coagulation disorders; Blood component transfusion; Factor VIIa; Liver diseases; Liver transplantation; Plasma

Indexed keywords

AMOTOSALEN; BLOOD CLOTTING FACTOR; BLOOD DERIVATIVE; DETERGENT; FRESH FROZEN PLASMA; METHYLENE BLUE; NONOXINOL 9; OCTAPLAS; OCTAPLAS SD; PARACETAMOL; PLACEBO; PLAS SD; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SOLVENT; WARFARIN;

BLOOD CLOTTING DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DRUG COST; EVIDENCE BASED MEDICINE; HEMOSTASIS; HUMAN; HYPERVOLEMIA; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; PARACENTESIS; PARTIAL THROMBOPLASTIN TIME; PLASMA TRANSFUSION; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZATION; REVIEW; THROMBOEMBOLISM; VALIDATION PROCESS;

BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; FACTOR VIIA; HUMANS; LIVER DISEASES; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS;

EID: 31144468335     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2005.01.034     Document Type: Review

References (60)

1. A. Filatov & N. Kartasevskij Die transfusion von menschlichem blutplasma als blutstillendes mittel Zentrallbl Chir 8 1935 441-445
2. L. Amitrano M.A. Guardascione V. Brancaccio & A. Balzano Coagulation disorders in liver disease Semin Liver Dis 22 2002 83-96
3. S.J. Stansworth S.J. Brunskill C.J. Hyde et al. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials Br J Haematol 126 2004 139-152
4. British Committee for Standards in Haematology, Blood Transfusion Task Force Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant Br J Haematol 126 2004 11-28
5. B.G. Gazzard J.M. Henderson & R. Williams Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy Gut 16 1975 617-620
6. I. Spector M. Corn & H.E. Ticktin Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease N Engl J Med 275 1966 1032-1037
7. W.I. Youssef F. Salazar S. Dasarathy et al. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: A dual phase study Am J Gastroenterol 98 2003 1391-1394
8. Consensus conference National Institutes of Health. Fresh-frozen plasma: indications and risks JAMA 253 1985 551-553
9. National Blood Resource Program Education Program Expert Panel Transfusion Alert: Indications for the Use of Red Blood Cells, Platelets, and Fresh Frozen Plasma. Publication No. 93297a 1993 National Institutes of Health Bethesda, MD
10. Fresh-Frozen Plasma, Cryoprecipitate, and Platelets Administration Practice Guidelines Development Task Force Practice parameter for the use of fresh frozen plasma, cryoprecipitate, and platelets JAMA 271 1994 777-781
11. American Society of Anesthesiologists Task Force on Blood Component Therapy Practice guidelines for blood component therapy Anesthesiology 84 1996 732-747
12. Expert Working Group Guidelines for red blood cell and plasma transfusion for adults and children Can Med Assoc J 156 11 supplement 1997 S1-S24
13. J. Becker D. Blackall C. Evans et al. Guidelines for Blood Utilization Review 2001 American Association of Blood Banks Bethesda, MD
14. R. Cable B. Carlson L. Chambers et al. Practice guidelines for blood transfusion: A compilation from recent peer-reviewed literature 2002 American National Red Cross Washington, DC
15. British Committee for Standards in Haematology Transfusion Task Force Transfusion guidelines for neonates and older children Br J Haematol 124 2004 433-453
16. W.H. Dzik Predicting hemorrhage using preoperative coagulation screening assays Curr Hematol Rep 3 2004 324-330
17. E.R. Burns S.N. Goldberg & B. Wenz Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time Am J Clin Pathol 100 1993 94-98
18. M. Ghany & J.H. Hoofnagle Approach to the patient with liver disease In D.L. Kasper E. Braunwald A.S. Fauci et al. (eds.) Harrison's Principles of Internal Medicine 16th edn 2005 McGraw-Hill New York 1808-1813
19. MELD/PELD Calculator. Richmond, VA: United Network for Organ Sharing; 2004. Online. Available at: http://www.unos.org [accessed December 5, 2004].
20. Liver organ sharing principles. Bristol: UK Transplant; 2003. Online. Available at: http://www.uktransplant.org [accessed November 21, 2004].
21. S.R. Deitcher Interpretation of the international normalised ratio in patients with liver disease Lancet 359 2002 47-48
22. M. Kovacs International normalised ratio and liver impairment (letter) Lancet 359 2002 1695
23. J.F. Trotter B. Brimhall R. Arjal & C. Phillips Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation Liver Transpl 10 2004 995-1000
24. Freeman Jr. RB, Wiesner RH, Roberts JP, et al. Improving liver allocation: MELD and PELD. In 2003 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1993-2002. p. X-4. Department of Health and Human Services, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI; 2003. Online. Available at: http://www.optn.org [accessed December 5, 2004].
25. P. Toy Plasma transfusion and alternatives In T.L. Simon W.H. Dzik & E.L. Snyder et al. (eds.) Rossi's Principles of Transfusion Medicine 3rd edn 2002 Lippincott Williams and Wilkins Philadelphia 335-340
26. F. Piccinino E. Sagnelli G. Pasquale & G. Giusti Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies J Hepatol 2 1986 165-173
27. D.B. McGill J. Rakela A.R. Zinsmeister & B.J. Ott A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 99 1990 1396-1400
28. B. Terjung I. Lemnitzer F.L. Dumoulin et al. Bleeding complications after percutaneous liver biopsy. An analysis of risk factors Digestion 67 2003 138-143
29. P.A. McVay & P.T Toy Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities Am J Clin Pathol 94 1990 747-753
30. A. Grant & J. Neuberger Guidelines on the use of liver biopsy in clinical practice Gut 45 supplement IV 1999 IV1-IV11
31. K. Ewe Bleeding after liver biopsy does not correlate with indices of peripheral coagulation Dig Dis Sci 26 1981 388-393
32. P.A. McVay & P.T.C.Y. Toy Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities Transfusion 31 1991 164-171
33. N.C. Fisher & D.J. Mutimer Central venous cannulation in patients with liver disease and coagulopathy - a prospective audit Intensive Care Med 25 1999 481-485
34. R.C.G. Martin II W.R. Jarnagin Y. Fong et al. The use of fresh frozen plasma after major hepatic resection for colorectal metastasis: Is there a standard for transfusion? J Am Coll Surg 196 2003 402-409
35. G. Ramsey Transfusion therapy in solid-organ transplantation In T.L. Simon W.H. Dzik & E.L. Snyder et al (eds.) Rossi's Principles of Transfusion Medicine 3rd edn 2002 Lippincott Williams and Wilkins Philadelphia 622-631
36. E. Laine R. Steadman L. Calhoun et al. Comparison of RBCs and FFP with whole blood during liver transplant surgery Transfusion 43 2003 322-327
37. A.L. Singer K.M. Olthoff H. Kim et al. Role of plasmapheresis in the management of acute hepatic failure in children Ann Surg 234 2001 418-424
38. D. Skerrett E. Mor S. Curtiss & K. Mohandas Plasmapheresis in primary dysfunction of hepatic transplants J Clin Apheresis 11 1996 10-13
39. A.K. Mandal K.E. King S.L. Humphreys et al. Plasmapheresis: An effective therapy for primary allograft nonfunction after liver transplantation Transplantation 70 2000 216-220
40. R.G. Lerner J. Nelson E. Sorcia et al. Evaluation of solvent/ detergent-treated plasma in patients with a prolonged prothrombin time Vox Sang 79 2000 161-167
41. L.M. Williamson C.A. Llewelyn N.C. Fisher et al. A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation Transfusion 39 1999 1227-1234
42. F.W.G. Leebeek M.R. Schipperus & H.H.D.M. van Vliet Coagulation factor levels in solvent/detergent-treated plasma (letter) Transfusion 39 1999 1150-1151
43. H. Beeck & P. Hellstern In vitro characterization of solvent/ detergent-treated human plasma and of quarantine fresh frozen plasma Vox Sang 74 supplement 1 1998 219-223
44. R. Sarode R. Yomtovian L.M. Williamson & C.A. Llewelyn Efficacy of SD-treated plasma during liver transplantation (letter) Transfusion 40 2000 886-888
45. J. De Jonge T.H.N. Groenland H.J. Metselaar et al. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP®) Anesth Analg 94 2002 1127-1131
46. Y. Ozier & C. Rieux Liver transplantation, solvent-detergent treated plasma and antifibrinolyics (letter) Anesth Analg 96 2003 1231
47. PLAS+SD (Pooled Plasma [Human] Solvent Detergent Treated): Important prescribing information. Safety Information, Center for Biologics Evaluation and Research. Bethesda, MD: Food and Drug Administration. October 20, 2000. Online. Available at: http://www.fda.gov/cber [accessed December 5, 2004].
48. Important new drug warning - PLAS+SD (Pooled Plasma, (Human) Solvent Detergent Treated). Safety Information, Center for Biologics Evaluation and Research. Bethesda, MD: Food and Drug Administration. March 29, 2002. Online. Available at: http://www.fda.gov/cber [accessed December 5, 2004].
49. B.G. Solheim A. Bergan F. Brosstad et al. Fibrinolysis during liver transplant and use of solvent/detergent virus-inactivated plasma (ESDEP®/Octaplas®). Anesth Analg 96 2003 1230-1231
50. L.M. Williamson R. Cardigan & C.V. Prowse Methylene blue-treated fresh-frozen plasma: What is its contribution to blood safety? Transfusion 43 2003 1322-1329
51. R. Atance A. Pereira & B. Ramirez Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate Transfusion 41 2001 1548-1552
52. P. Mintz R. Steadman D. Blackall et al. Pathogen inactivation of plasma using S-59 and UVA light is efficacious and well tolerated in the treatment of end-stage liver disease patients-the STEP AC trial (abstract) Transfusion 42 supplement 2002 15S
53. H.R. Roberts D.M. Monroe & G.C. White The use of recombinant factor VIIa in the treatment of bleeding disorders Blood 104 2004 3858-3864
54. J. Bosch D. Thabut F. Bendtsen et al. Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: A randomized, double-blind trial Gastroenterology 127 2004 1123-1130
55. R.M. Planinsic G. Testa S. Emre et al. Safety and efficacy of single bolus dose of recombinant factor VIIa in patients undergoing orthotopic liver transplantation: A randomized multi-center study (abstract) Hepatology 36 4 Pt 2 2002 660A
56. P. Lodge S. Jonas D. Jaeck M.J. Fridberg Recombinant factor VIIa (NovoSeven®) in partial hepatectomy: A randomized, placebo-controlled, double-blind clinical trial (abstract) Hepatology 36 4 Pt 2 2002 211A
57. J.P.A. Lodge Hemostasis in liver resection surgery Semin Hematol 41 supplement 1 2004 70-75
58. V.M. Shami S.H. Caldwell E.E. Hespenheide et al. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy Liver Transpl 9 2003 138-143
59. L. Jeffers N. Chalasani L. Balart et al. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy Gastroenterology 123 2002 118-126
60. L.T. Goodnough D.M. Lublin L. Zhang et al. Transfusion medicine service policies for recombinant factor VIIa administration Transfusion 44 2004 1325-1331